31 107

Cited 0 times in

Fluconazole Therapy for 5 cases of Cryptococcal Meningitis

Other Title
크립토코크스 뇌막염에서 Fluconazole 치험 5예
Authors
김, 정연; 석, 승한; 허, 균
Citation
Taehan Sin'gyŏngkwa Hakhoe chi : sin'gyŏnghak, 12(2):358-362, 1994
Journal Title
Taehan Sin'gyŏngkwa Hakhoe chi : sin'gyŏnghak; Journal of the Korean Neurological Association : neurology
ISSN
1225-70442288-985X
Abstract
Cryptococcal meningitis is a relatively common central nervous system infection by Cryptococcus neoformans. Before the introduction of amphotericin B in 1956, cryptococcal infection of the central nervous system had been almost uniformly fatal. Although amphotericin B(alone or in combination with flucytosine) has been the standard therapeutic regimen, problems such as modest efficacy, nephrotoxcity, other clinically significant toxicities, and the inconvinience of intravenous dosing have led to search for a new antimycotic agents. Fluconazole is a new therapeutic agent which is effective as amphoterin B. Accumulating evidence suggests that the antifungal triazole fluconazole represent an advance in the treatment of cryptococcal meningitis, particulary in acquired immunodeficiency syndrom patients. Thus we report clinical experiences of fluconazole therapy for 5 cases of cryptococcal meningitis. Four of 5 patients are improved clinically and microbiologically, 1 of 5 patients is expired due to concomittent tuberculous infection.
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Neurology
Full Text Link
Files in This Item:
358-362.PDFDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse